A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET).


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2022
Historique:
received: 20 10 2022
accepted: 16 11 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 4 1 2023
Statut: epublish

Résumé

Bloodstream infections (BSIs), especially hospital-acquired BSIs, are a major cause of morbidity and mortality. However, the details about the pathogens and antimicrobial resistance profile of BSIs across China are still lacking. An investigation was conducted in 10 large teaching hospitals from seven geographic regions across China in 2016 based on China Antimicrobial Surveillance Network (CHINET) to profile the clinical and etiological features of BSIs. A total of 2,773 cases of BSIs were identified, a majority (97.3%) of which were monomicrobial. Overall, 38.4% (1,065/2,773) were community-acquired BSIs (CABSIs), and 61.6% (1,708/2,773) were hospital-acquired BSIs (HABSIs). Of the 2,861 pathogenic BSI isolates, 67.5% were Gram-negative bacteria, 29.6% were Gram-positive bacteria, and 2.9% were fungi. The top BSI pathogens were The findings about BSIs in teaching hospitals across China add more scientific evidence to inform the appropriate management of the disease.

Sections du résumé

Background
Bloodstream infections (BSIs), especially hospital-acquired BSIs, are a major cause of morbidity and mortality. However, the details about the pathogens and antimicrobial resistance profile of BSIs across China are still lacking.
Methods
An investigation was conducted in 10 large teaching hospitals from seven geographic regions across China in 2016 based on China Antimicrobial Surveillance Network (CHINET) to profile the clinical and etiological features of BSIs.
Results
A total of 2,773 cases of BSIs were identified, a majority (97.3%) of which were monomicrobial. Overall, 38.4% (1,065/2,773) were community-acquired BSIs (CABSIs), and 61.6% (1,708/2,773) were hospital-acquired BSIs (HABSIs). Of the 2,861 pathogenic BSI isolates, 67.5% were Gram-negative bacteria, 29.6% were Gram-positive bacteria, and 2.9% were fungi. The top BSI pathogens were
Conclusions
The findings about BSIs in teaching hospitals across China add more scientific evidence to inform the appropriate management of the disease.

Identifiants

pubmed: 36590586
doi: 10.3389/fcimb.2022.1075185
pmc: PMC9798236
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cefepime 807PW4VQE3
sultamicillin 65DT0ML581
Ceftazidime 9M416Z9QNR
Anti-Infective Agents 0

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1075185

Informations de copyright

Copyright © 2022 Hu, Yuan, Yang, Xu, Huang, Hu, Ai, Zhuo, Su, Shan, Du, Yu, Lin, Sun, Chen, Xu, Zhang, Wang, He, Ni, Zhang, Lin, Zhu and Zhang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor YWT declared a past co-authorship with the authors FH and YY.

Références

Lancet Infect Dis. 2017 Oct;17(10):1042-1052
pubmed: 28818544
Asia Pac J Public Health. 2017 Jul;29(5):451-461
pubmed: 28719790
Infect Drug Resist. 2021 Feb 24;14:731-742
pubmed: 33658810
Int J Clin Pract. 2016 Sep;70(9):706-11
pubmed: 27291693
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S128-S134
pubmed: 30423045
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31010862
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Diagn Microbiol Infect Dis. 2020 Jun;97(2):115016
pubmed: 32111415
Medicine (Baltimore). 2008 Jul;87(4):234-249
pubmed: 18626306
J Antimicrob Chemother. 2016 Dec;71(12):3453-3458
pubmed: 27609052
Antimicrob Resist Infect Control. 2019 Mar 29;8:61
pubmed: 30976388
Front Cell Infect Microbiol. 2020 Jul 03;10:314
pubmed: 32719751
Diagn Microbiol Infect Dis. 2004 Sep;50(1):59-69
pubmed: 15380279
Expert Rev Anti Infect Ther. 2010 Jul;8(7):815-29
pubmed: 20586566
Clin Infect Dis. 2021 Apr 8;72(7):1109-1116
pubmed: 33830222

Auteurs

Fupin Hu (F)

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission, Shanghai, China.

Lili Yuan (L)

Department of Hospital Infection Management, Huashan Hospital, Fudan University, Shanghai, China.

Yang Yang (Y)

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission, Shanghai, China.

Yuanhong Xu (Y)

Clinical Microbiology Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Ying Huang (Y)

Clinical Microbiology Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Yunjian Hu (Y)

Clinical Microbiology Laboratory, Beijing Hospital, Beijing, China.

Xiaoman Ai (X)

Clinical Microbiology Laboratory, Beijing Hospital, Beijing, China.

Chao Zhuo (C)

Department of Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Danhong Su (D)

Clinical Microbiology Laboratory, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Bin Shan (B)

Clinical Microbiology Laboratory, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

Yan Du (Y)

Clinical Microbiology Laboratory, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

Yunsong Yu (Y)

Department of Infectious Disease, Sir Run Run Shaw Hospital, Affiliated to Zhejiang University School of Medicine, Hangzhou, China.

Jie Lin (J)

Clinical Microbiology Laboratory, Sir Run Run Shaw Hospital, Affiliated to Zhejiang University School of Medicine, Hangzhou, China.

Ziyong Sun (Z)

Clinical Microbiology Laboratory, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

Zhongju Chen (Z)

Clinical Microbiology Laboratory, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

Yingchun Xu (Y)

Clinical Microbiology Laboratory, Peking Union Medical College Hospital, Beijing, China.

Xiaojiang Zhang (X)

Clinical Microbiology Laboratory, Peking Union Medical College Hospital, Beijing, China.

Chuanqing Wang (C)

Clinical Microbiology Laboratory, Children's Hospital of Fudan University, Shanghai, China.

Leiyan He (L)

Clinical Microbiology Laboratory, Children's Hospital of Fudan University, Shanghai, China.

Yuxing Ni (Y)

Clinical Microbiology Laboratory, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

Yibo Zhang (Y)

Department of Hospital Infection Management, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

Dongfang Lin (D)

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission, Shanghai, China.

Demei Zhu (D)

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission, Shanghai, China.

Yingyuan Zhang (Y)

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH